Skip to content

Social media-delivered care for improving hypertension management in the Tibetan plateau: the WECARE randomised controlled trial protocol

Social media-delivered care for improving hypertension management in the Tibetan plateau: the WECARE randomised controlled trial protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049535
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-08-03
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

1:WECARE hypertension mangement program

Sponsors

China Medical Board
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Individuals will be eligible if they are WeChat users, have an operating smartphone, and are aged between 18 or over. Have had a medical history of hypertension documented for six or more months and have at least two measures in the last three months indicating poor control. Participants will be also required to have sufficient Chinese or Tibetan language proficiency, as well as digital literacy in using WeChat and the internet, to enable WeChat-based health education and communication with the WECARE team.

Exclusion criteria

Exclusion criteria: Individuals will be excluded if they are currently receiving any mHealth-based hypertension management programme, have no internet access at their place of residence, or are unable to operate a smartphone, or Bluetooth-enabled BP monitor for the purpose of the trial (e.g., vision, hearing, cognitive or dexterity impairment). Other exclusion criteria include the following: a known cause of secondary hypertension; acute coronary syndrome, coronary revascularisation or stroke, within the past three months; heart failure; or receiving haemodialysis or chemotherapy.

Design outcomes

Primary

MeasureTime frame
The difference in change in mean systolic BP between the two follow-up points;

Secondary

MeasureTime frame
Change in mean Diastolic BP;Change in cardiovascular health literacy,;Adherence to antihypertensive medications;CVD risk factors including both behavioural and psychosocial factors;

Countries

China

Contacts

Public ContactTashi Dorje

Curtin University

woshiyak@gmail.com+61 8 6152 0872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026